A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interaction

Wakana Saso , Senko Tsukuda , Hirofumi Ohashi , Kento Fukano , Ryo Morishita , Satoko Matsunaga , Mio Ohki , Akihide Ryo , Sam-Yong Park , Ryosuke Suzuki , Hideki Aizaki , Masamichi Muramatsu , Camille Sureau (1) , Takaji Wakita (2) , Tetsuro Matano , Koichi Watashi (3)

1 INTS - Institut National de la Transfusion Sanguine [Paris]
2 National Institute of Infectious Diseases [Tokyo]
3 Department of Virology II

Domaines: Virologie

Wakana Saso, Senko Tsukuda, Hirofumi Ohashi, Kento Fukano, Ryo Morishita, et al.. A new strategy to identify hepatitis B virus entry inhibitors by AlphaScreen technology targeting the envelope-receptor interaction. Biochemical and Biophysical Research Communications, 2018, 501 (2), pp.374-379. ⟨10.1016/j.bbrc.2018.04.187⟩. ⟨hal-02370847⟩